Radiation therapy for limited-stage small-cell esophageal cancer

Kenji Nemoto, Heng Jiang Zhao, Takumi Goto, Yoshihiro Ogawa, Yoshihiro Takai, Haruo Matsushita, Ken Takeda, Chiaki Takahashi, Haruo Saito, Shogo Yamada

Research output: Contribution to journalArticlepeer-review

49 Citations (Scopus)


Between 1985 and 1999, 20 patients with limited-stage smallcell carcinoma of the esophagus (SCEC) received radiation therapy at Tohoku University Hospital and Miyagi Cancer Center Hospital. Twelve patients received definitive radiation therapy and eight patients received postoperative prophylactic irradiation after surgery. The 1-, 2-, and 5-year survival rates of all cases were 44%, 37%, and 19%, respectively. Distant metastasis was the most frequent pattern of recurrence. Survival rates differed significantly between the 6 patients who were not treated with chemotherapy (median survival time, 5 months) and the 14 patients who were (24 months) (p = 0.0061). Good local control rates can be obtained by definite or postoperative radiation therapy for SCEC. However, SCEC should be regarded as a systemic disease, and chemotherapy should be given. Multiinstitutional studies are needed to obtain sufficiently large populations for investigation and optimization of local therapy for this disease.

Original languageEnglish
Pages (from-to)404-407
Number of pages4
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Issue number4
Publication statusPublished - 2002


  • Chemotherapy
  • Esophageal cancer
  • Radiotherapy
  • Small-cell carcinoma
  • Surgery

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Radiation therapy for limited-stage small-cell esophageal cancer'. Together they form a unique fingerprint.

Cite this